Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102972973 | 10297297 | 3 | F | 201402 | 20160816 | 20140711 | 20160817 | EXP | US-ROCHE-1432453 | ROCHE | 60.80 | YR | F | Y | 61.74000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102972973 | 10297297 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | PORT INFUSION | Y | 103792 | SOLUTION FOR INFUSION | /wk | |||||||
| 102972973 | 10297297 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | PORT INFUSION | Y | 103792 | SOLUTION FOR INFUSION | Q3W | |||||||
| 102972973 | 10297297 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | PORT INFUSION | Y | 103792 | SOLUTION FOR INFUSION | Q3W | |||||||
| 102972973 | 10297297 | 4 | C | TAXOTERE | DOCETAXEL | 1 | Unknown | 0 | Q3W | ||||||||||
| 102972973 | 10297297 | 5 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | 0 | 25 | MG | Q3W | ||||||||
| 102972973 | 10297297 | 6 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 102972973 | 10297297 | 7 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 0 | 25 | MG | QID | ||||||||
| 102972973 | 10297297 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 600 | MG | QID | ||||||||
| 102972973 | 10297297 | 9 | C | ACETYLCHOLINE | ACETYLCHOLINE CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102972973 | 10297297 | 1 | Breast cancer |
| 102972973 | 10297297 | 4 | Breast cancer |
| 102972973 | 10297297 | 5 | Breast cancer |
| 102972973 | 10297297 | 8 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102972973 | 10297297 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102972973 | 10297297 | Fibromyalgia | |
| 102972973 | 10297297 | Heart rate increased | |
| 102972973 | 10297297 | Heart rate irregular | |
| 102972973 | 10297297 | Hot flush | |
| 102972973 | 10297297 | Hyperhidrosis | |
| 102972973 | 10297297 | Muscular weakness | |
| 102972973 | 10297297 | Neuropathy peripheral | |
| 102972973 | 10297297 | Platelet count decreased | |
| 102972973 | 10297297 | Swelling | |
| 102972973 | 10297297 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102972973 | 10297297 | 1 | 201402 | 201406 | 0 | |
| 102972973 | 10297297 | 2 | 20140623 | 0 | ||
| 102972973 | 10297297 | 3 | 201402 | 0 | ||
| 102972973 | 10297297 | 4 | 201402 | 201406 | 0 | |
| 102972973 | 10297297 | 5 | 201402 | 201406 | 0 |